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better in the breast-fed arm, significantly so in the first 6
months. The cardinal point to remember is that these
similarities in outcome, and the nutritional benefit of breast-
feeding, occurred after 24 months (median duration of breast-
feeding 17 months), when the HIV infection rate in the breast-
feeding arm was a whopping 37% compared with 21% in the
formula arm. Accordingly breast-feeding over this prolonged
period remained effective for these outcomes despite the very
high HIV infection rate; the obvious answer is to reduce HIV
transmission through breast-feeding while retaining its
advantages! Six months provides adequate benefits of breast-
feeding, and the transmission risk of HIV is at worst about 5%
(the latter is from a meta-analysis of nine African trials
involving 4 085 children).4 If our group’s hypothesis is correct
this figure may be even lower with exclusive breast-feeding.
What is critical to the thrust of this letter is that in the
Nairobi trial all women ‘had access to potable water, extensive
health education regarding safe preparation of formula, a
reliable supply of formula, and access to medical care for their
infants’. So breast-feeding stood up to comparison with
formula in a developing country setting, which is as good as it
can get for minimising the disadvantages of formula.
There are other examples of breast-feeding in urban
environments. In Durban and Harare (an extremely large trial)
studies are detecting substantial benefits in children of HIV-
infected mothers who breast-feed in preference to formula-
feeding.
We have to promote solutions that are not abstracted from
this continent’s priorities and that respect the durability and
strength of African traditions; breast-feeding is more than just
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Auto-antibody testing in
obstetric patients
To the Editor: We read with interest the article by Afman et al.1
on the relationship of auto-antibodies and obstetric outcome in
a tertiary high-risk obstetric unit. In our view the lack of an
association between antinuclear antibodies (ANAs) and
adverse pregnancy outcome may be due to a fundamental
error in interpretation of the ANA results. The authors have
grouped the 33 true ANA-positive patients with the 13 patients
who had only an anti-cytoplasmic pattern on indirect
immunofluorescence (IIF) testing. The latter staining pattern is
a ‘by-product’ of the IIF test using HEp-2 cells, and in this
study is likely to be due to anti-parietal and anti-smooth
muscle antibodies that were presumably confirmed on tissue
substrate (method not given in paper). By definition, antibodies
directed at cytoplasmic components cannot be considered to be
ANAs. Hence, the comparison should have been between the
33 true ANA- positive patients and relevant control patients. A
secondary issue is that negative IIF does not rule out the
presence of anti-Ro antibodies even when HEp-2 cells are used
as substrate. Anti-Ro antibodies are highly associated with the
rare event of neonatal lupus and need to be sought by other
methods if there is any suspicion of this condition.
Secondly, it would have been helpful to know the total
number of patients in the two groups who were HIV-positive,
and the frequencies of the respective auto-antibodies. We also
note the finding that anticardiolipin (ACL) antibodies were
more frequent in women with severe pre-eclampsia. In a
previous study based on our own experience in a routine
antenatal clinic, ACL antibodies were poorly predictive for pre-
eclampsia,2 so the test may be more useful where there is a
higher pretest risk of an associated event. Finally, we feel the
title of the paper is not an accurate reflection of the study. ACL
antibodies are not directed against nuclear antigens. ‘Auto-
antibody testing in obstetric patients’ might be a more accurate
title and a better reflection of the nature of the study.
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To the Editor: Members of the Southern African Underwater
and  Hyperbaric Medical Association (SAUHMA), a special
interest group of  the South African Medical Association, were
shocked to learn of the death of the Eloff brothers when a
chamber they apparently built and used  exploded, killing
498
them both.  A third member of the family was injured, and
there was extensive damage to property.
In brief, hyperbaric oxygen (HBO) therapy uses oxygen
under pressure in a chamber in a well-controlled manner as a
primary or adjunctive treatment for a number of  recognised
medical and surgical conditions.
SAUHMA’s executive and its members have received a
number of calls from concerned patients currently undergoing
HBO therapy at recognised and certified treatment facilities.
Patients and relatives are naturally concerned about their own
safety after the terrible event.
Any avoidable accident that involves loss of life, injury, or
damage to property is indeed a tragic occurrence.  
Worldwide accidents involving pressure vessels are rare.
While the facts of this case are not yet understood, or in fact
even known, SAUHMA is able to provide the assurance that,
provided the basic rules pertaining to hyperbaric equipment
are adhered to, hyperbaric medicine is and will remain a safe
and well-controlled form of treatment.  
The authorities in South Africa have provided us with
modern and relevant legislation and standards that govern and
guide the use of any potentially lethal or dangerous gas
containers.
The Occupational Health and Safety Act (Act No. 85 of 1993)
and the Vessels under Pressure Regulations incorporated
therein contain a clear blueprint of the duties and  respon-
sibilities of all the parties, viz. the users, manufacturers and
suppliers.  Once can read up on the matter using the link
http://www.labourwise.co.za/laws/Safety.PressureVessels.htm
#Design which  is offered free of charge.  In addition, we have
an SABS Code of  Practice (SANS 0377-1) for Pressure  Vessels
for Human Occupancy, and since 1999 we have had the
SAUHMA Risk Assessment Guide which provides guidance
for  medical practitioners, operational staff and anyone tasked
with the responsibility of ensuring that a facility is safe. All
these documents are clear, appropriate and cover all the aspects
of concern, and all of them have been compiled by people with
a wealth of practical experience.
Safety is, of course, only partly ensured by a chamber being
built in compliance with rules and regulations; it is essential
that those operating and maintaining the equipment are
trained,  experienced and competent to do so.  This is all well
described within our legislation.
We do not lack for clear or relevant guidance in our country.
Based on over 80 years of relevant experience from around the
world, nowhere has any compliant facility ever seen the effects
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that this horrific accident have brought home to us.  What we
do need to realise though, is that we have to understand the
risks involved and therefore perform our duties in such a way
as to minimise, remove or at least contain these risks if we are
to be truly safe.  Safety is vitally important and understanding
is the key. 
We earnestly appeal to all people contemplating the use of
HBO to ensure three things before entering any chamber:  (i)
ensure that HBO is, in fact, medically indicated and advisable
for the particular illness or condition; (ii) ensure that the
chamber is tested, licensed and approved by the Department of
Labour and that such approval is up to date; and (iii) ensure
that the chamber personnel and operators are fully trained and
registered in medical HBO administration.
SAUHMA is always very willing to offer expert advice and
help to anyone who might need assistance with regard to HBO
and its medically approved indications Simply contact us
through Divers Alert Network (DAN) at (011) 254-1991/2.
SAUHMA also has in its members a wealth of expertise and we
would gladly assist the authorities with their investigation of
the incident.





Psychopathology and coping in
recently diagnosed HIV/AIDS
patients — the role of gender
To the Editor: Olley et al.1 provide valuable insight into the
burden of mental illness among patients with HIV/AIDS and
make useful recommendations. However, there is no evidence
to support the hypothesis that ‘women with HIV/AIDS may
face greater stigmatisation’. Stigma is a complex concept and
confounds the relationship between HIV and mental illness.
Olley et al.1 offer no measure or indication of ‘high levels of
stigmatisation and stress faced by HIV/AIDS patients in South
Africa’. Berger et al.2 have recently validated an HIV stigma
scale, which would have provided valuable information in this
sample.
The reliability of assessing sexual risk behaviour in a single
interview using an adapted scale is questionable.  Gender
differences in HIV infection in this sample and the general
population indicate that it is women who are more at risk of
HIV infection. There is a larger body of evidence to support the
claim that women are more likely than men to ‘exchange sex
for drugs and money’.3 Social inequality and poverty are the
factors responsible for women’s vulnerability to HIV infection.4
This contradicts the assertion that men ‘exchange sex for drugs
and money’.1 Scales and other psychometric tests can improve
qualitative research.  However Barbour5 warns that
‘overzealous and uncritical use can be counterproductive’.5 Its
inappropriate use will threaten construct validity.  This, in
addition to the selection bias, may have contributed to the
inability to detect gender differences in this sample.
Dinesh Singh
Columbia University
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Tariff relativity
To the Editor: It is most unusual to find in one journal, two
writers with whom I served on Federal Council. With Dougie
Gurnell we put together the Tariff for GPs. René le Roex was
Chairman of the CCCP, of which I was a member. Both wrote
in the April issue of the SAMJ,1,2 and it is to René’s article that I
refer.2 He makes no mention of all the effort we put into
maintaining the relativity between the various disciplines,
which had been established by several Commissions. I wrote to
the Commissioner of the Competition Commission and said
that their policy would eliminate the above relativity and
create chaos. This is precisely what has happened as each
group now negotiates its own tariff with the various
Administrators and relativity has gone down the plughole.
All those years of effort are being wasted in this new era
where medicine has become a business, no longer a calling,
and certainly no longer fun. It used to be a pleasure to take on
a family and live with them, at least through their health
troubles, visiting them in their homes, when necessary even at
night. All gone — now it appears to be survival with no
concern but for oneself.
Maybe the bad old days weren’t so bad after all, despite the
advent of third party payers.
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